.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Dow
Fish and Richardson
Teva
Daiichi Sankyo
Argus Health
McKesson
Moodys
US Department of Justice
Baxter

Generated: September 22, 2017

DrugPatentWatch Database Preview

VALRELEASE Drug Profile

« Back to Dashboard

What is the patent landscape for Valrelease, and when can generic versions of Valrelease launch?

Valrelease is a drug marketed by Roche and is included in one NDA.

The generic ingredient in VALRELEASE is diazepam. There are eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.

Summary for Tradename: VALRELEASE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list48
Patent Applications: see list5,359
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VALRELEASE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
VALRELEASE
diazepam
CAPSULE, EXTENDED RELEASE;ORAL018179-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VALRELEASE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
VALRELEASE
diazepam
CAPSULE, EXTENDED RELEASE;ORAL018179-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Dow
Deloitte
Moodys
AstraZeneca
Novartis
Julphar
Chubb
Boehringer Ingelheim
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot